iDNA Genomics Public (CYS:IDNA) Gross Margin %: 0.00% (As of . 20)


CYS:IDNA iDNA Genomics Public Ltd CYS:IDNA
23 GF Score
Price €22.80
! 2 Warning Signs
View Full Analysis

What is iDNA Genomics Public Gross Margin %?

iDNA Genomics Public CYS:IDNA 23 Gross Margin % is 0.00% as of . 20. GuruFocus rates CYS:IDNA with a GF Score™ of 23/100. The stock has 2 warning signs investors should review.

Gross Margin % is calculated as gross profit divided by its revenue. iDNA Genomics Public's Gross Profit for the six months ended in . 20 was €0.00 Mil. iDNA Genomics Public's Revenue for the six months ended in . 20 was €0.00 Mil. Therefore, iDNA Genomics Public's Gross Margin % for the quarter that ended in . 20 was 0.00%. If there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.


The historical rank and industry rank for iDNA Genomics Public's Gross Margin % or its related term are showing as below:


CYS:IDNA's Gross Margin % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 51.31
* Ranked among companies with meaningful Gross Margin % only.

iDNA Genomics Public had a gross margin of N/A% for the quarter that ended in . 20 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for iDNA Genomics Public was 0.00% per year.

iDNA Genomics Public  (CYS:IDNA) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

iDNA Genomics Public had a gross margin of N/A% for the quarter that ended in . 20 => No sustainable competitive advantage

Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.

iDNA Genomics Public Gross Margin % Related Terms

iDNA Genomics Public Gross Margin % Historical Data

* Premium members only.

The historical data trend for iDNA Genomics Public's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

iDNA Genomics Public Gross Margin % Chart

iDNA Genomics Public Annual Data
Trend
Gross Margin %

iDNA Genomics Public Semi-Annual Data
Gross Margin %

CYS:IDNA vs : Gross Margin % Comparison

For the Diagnostics & Research subindustry, iDNA Genomics Public's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

iDNA Genomics Public Gross Margin % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, iDNA Genomics Public's Gross Margin % distribution charts can be found below:

* The bar in red indicates where iDNA Genomics Public's Gross Margin % falls into.


CYS:IDNA
23GF Score
iDNA Genomics Public Ltd CYS:IDNA
Gross Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

iDNA Genomics Public Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

iDNA Genomics Public's Gross Margin for the fiscal year that ended in . 20 is calculated as

Gross Margin % (A: . 20 )=Gross Profit (A: . 20 ) / Revenue (A: . 20 )
=0 /
=(Revenue - Cost of Goods Sold) / Revenue
=( - ) /
=N/A %

iDNA Genomics Public's Gross Margin for the quarter that ended in . 20 is calculated as


Gross Margin % (Q: . 20 )=Gross Profit (Q: . 20 ) / Revenue (Q: . 20 )
=0 /
=(Revenue - Cost of Goods Sold) / Revenue
=( - ) /
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Frequently Asked Questions Learn more about Gross Margin % →
What does a Gross Margin % of 0.00% mean?
iDNA Genomics Public (CYS:IDNA) has a Gross Margin % of 0.00% as of . 20. Gross margin is the ratio of total gross profit to net sales. View historical data on iDNA Genomics Public and its competitors.
Is iDNA Genomics Public's Gross Margin % too high?
iDNA Genomics Public's current Gross Margin % is 0.00%. Overall, iDNA Genomics Public has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does iDNA Genomics Public's Gross Margin % compare to ?
iDNA Genomics Public's Gross Margin % of 0.00% can be compared against companies in the Medical Diagnostics & Research industry. The industry median Gross Margin % is 51.31. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Diagnostics & Research company?
The median Gross Margin % among Medical Diagnostics & Research companies is 51.31, based on 195 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on iDNA Genomics Public and its competitors. For the Medical Diagnostics & Research industry, the median Gross Margin % is 51.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. iDNA Genomics Public's current Gross Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iDNA Genomics Public stock overvalued right now?
iDNA Genomics Public (CYS:IDNA) has a current Gross Margin % of 0.00%. The current Gross Margin % is 0.00%. iDNA Genomics Public's overall GF Score™ is 23/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For iDNA Genomics Public (CYS:IDNA), the current Gross Margin % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

iDNA Genomics Public Business Description

Comparable Companies
Address 7 Hatzidaki Street, Trypiotis, Nicosia, CYP, 1066
iDNA Genomics Public Ltd operates in the field of genomics and biotechnology and specializes in personalized health care. Its purpose is to develop and provide genetic tests in the field of genomics, through professionals (Medical Genomics) and directly to the consumer (Direct-to-Consumer Genomics).
23GF Score

Get the complete analysis for CYS:IDNA

Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€22.80
Price